No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis

Inflammation

Volumn 38, Issue 4, 2015, Pages 1731-1737

  Chalmers, James D ^a   Matsushita, Misao ^b   Kilpatrick, David C ^c   Hill, Adam T ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b TOKAI UNIVERSITY   (Japan)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

case control study; complement; ficolin; innate immunity; mannose binding lectin; phagocytosis; tuberculosis

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; FICOLIN 2; FICOLIN 3; MANNOSE BINDING LECTIN; MASP2 PROTEIN; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RISK FACTOR; SIGNAL TRANSDUCTION; ADOLESCENT; BLOOD; COHORT ANALYSIS; DISEASE PREDISPOSITION; GENETICS; MIDDLE AGED; PHYSIOLOGY; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84937251575     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0150-0     Document Type: Article

References (34)

1. Stop TB Partnership and World Health Organization. 2006. The Global Plan to Stop TB 2006–2015: actions for life towards a world free of tuberculosis. WHO/HTM/STB/2006. 35. Geneva: World Health Organization.
2. Gagneux, S., K. DeRiemer, T. Van, et al. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 103(8): 2869–2873.
3. Houben, E.N., L. Nguyen, and J. Pieters. 2006. Interaction of pathogenic mycobacteria with the host immune system. Current Opinion in Microbiology 9(1): 76–85.
4. Fortune, A., A. Solache, A. Jaeger, et al. 2004. Mycobacterium tuberculosis inhibits macrophage response to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. Journal of Immunology 172(10): 6272–6280.
5. Sallakci, N., M. Coskun, Z. Berber, et al. 2007. Interferon-γ gene +874T-A polymorphism is associated with tuberculosis and gamma interferon response. Tuberculosis 87(3): 225–230.
6. Roth, D.E., G. Soto, F. Arenas, et al. 2004. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. Journal of Infectious Diseases 190(5): 920–927.
7. Tosh, K., S.J. Campbell, K. Fielding, et al. 2006. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proceedings of the National Academy of Sciences of the United States of America 103(27): 10364–10368.
8. Flores-Villanueva, P.O., J.A. Ruiz-Morales, C. Song, et al. 2005. A functional promoter polymorphism in monocyte chemoattractant protein–1 is associated with increased susceptibility to pulmonary tuberculosis. Journal of Experimental Medicine 202: 1649–1658.
9. Bellamy, R. 2005. Genetic susceptibility to tuberculosis. Clinics in Chest Medicine 26(2): 233–246.
10. Kilpatrick, D.C. 2003. Introduction to mannan-binding lectin. Biochemical Society Transactions 31(4): 745–747.
11. Neth, O., D.L. Jack, and A.W. Dodds. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infection and Immunity 68(2): 688–693.
12. Eisen, D.P., M.M. Dean, M.A. Boermeester, K.J. Fidler, A.C. Gordon, G. Kronborg, J.F. Kun, Y.L. Lau, A. Payeras, and H. Valdimarsson. 2008. Low serum mannose binding lectin level increases the risk of death due to pneumococcal infection. Clinical Infectious Diseases 47(4): 510–516.
13. Lambourne, J., D. Agranoff, R. Herbrecht, et al. 2009. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clinical Infectious Diseases 49(10): 1486–1491.
14. Chalmers, J.D., B.J. McHugh, C.J. Doherty, J.R.W. Govan, D.C. Kilpatrick, and A.T. Hill. 2013. Mannose binding lectin deficiency and disease severity in non-CF bronchiectasis: a prospective study. Lancet Respiratory Medicine 1(3): 175–274.
15. Kang, P., A. Azad, J. Torrelles, et al. 2005. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. Journal of Experimental Medicine 202: 987–999.
16. Capparelli, R., M. Iannaccone, D. Palumbo, et al. 2009. Role played by human mannose-binding lectin polymorphisms in pulmonary tuberculosis. Journal of Infectious Diseases 199: 666–672.
17. Søborg, C., H. Madsen, Å. Andersen, T. Lillebaek, A. Kok-Jensen, and P. Garred. 2003. Mannose-binding lectin polymorphisms in clinical tuberculosis. Journal of Infectious Diseases 188: 777–782.
18. Denholm, J.T., E.S. McBryde, and D.P. Eisen. 2010. Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clinical and Experimental Immunology 162(1): 84–90.
19. Ezekowitz, R., L. Day, and G. Herman. 1988. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. Journal of Experimental Medicine 167: 1034–1046.
20. Kilpatrick, D.C., and J.D. Chalmers. 2012. Human L-ficolin (ficolin-2) and its clinical significance. Journal of Biomedicine and Biotechnology 2012: 138797.
21. Carroll, M.V., N. Lack, E. Sim, A. Krarup, and R.B. Sim. 2009. Multiple routes of complement activation by Mycobacterium bovis BCG. Molecular Immunology 46(16): 3367–3378.
22. Kilpatrick, D.C., T. Fujita, and M. Matsushita. 1999. P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunology Letters 67(2): 109–112.
23. Kilpatrick, D.C., J.D. Chalmers, S.L. MacDonald, et al. 2009. Stable bronchiectasis is associated with low serum L-ficolin concentrations. The Clinical Respiratory Journal 3(1): 29–33.
24. Kilpatrick, D.C., B.H. Bevan, and W.A. Liston. 1995. Association between mannan binding protein deficiency and recurrent miscarriage. Molecular Human Reproduction 10: 2501–2505.
25. Muhlebach, M.S., S.L. MacDonald, B. Button, et al. 2006. Association between mannose-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clinical and Experimental Immunology 145(2): 302–307.
26. Schlapbach, L.J., C. Aebi, M. Otth, et al. 2007. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatric Infectious Disease Journal 26(11): 989–994.
27. Herpers, B.L., H. Endeman, B.A.W. De Jong, et al. 2009. Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clinical and Experimental Immunology 156(3): 488–494.
28. Garred, P., C. Richter, A. Andersen, et al. 1997. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scandinavian Journal of Immunology 46: 204–208.
29. Hoal-van Helden, E., J. Epstein, T. Victor, et al. 1999. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatric Research 45: 459–464.
30. Selvaraj, P., M. Jawahar, D. Rajeswari, K. Alagarasu, M. Vidyarani, and P. Narayanan. 2006. Role of mannose binding lectin gene variants on its protein levels and macrophage phagocytosis with live Mycobacterium tuberculosis in pulmonary tuberculosis. FEMS Immunology And Medical Microbiology 46: 433–437.
31. Cosar, H., F. Ozkinay, H. Onay, et al. 2008. Low levels of mannose-binding lectin confers protection against tuberculosis in Turkish children. European Journal of Clinical Microbiology and Infectious Diseases 27: 1165–1169.
32. Schlesinger, L.S., C.G. Bellinger-Kawahara, N.R. Payne, and M.A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. Journal of Immunology 144: 2771–2780.
33. Hummelshoj, T., L. Munthe-Fog, H.O. Madsen, T. Fujita, M. Matsushita, and P. Garred. 2005. Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Human Molecular Genetics 14: 1651–1658.
34. Honore, C., S. Rorvig, L. Munthe-Fog, et al. 2008. The innate pattern recognition molecule ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Molecular Immunology 45(10): 2782–2789.